Work

Abstract CT175: ctDNA clearance as a prognostic biomarker in ES-SCLC: Insights from the LUMINANCE phase IIIb study

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct175

Authors: Gozde Kar, Mingchao Xie, Niels Reinmuth, Filippo de Marinis, Mustafa Özgüroğlu, Natasha B. Leighl, Ugochinyere Emeribe, Natalia Donner, Yashaswi Shrestha

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States), German Center for Lung Research, European Institute of Oncology, Istanbul University-Cerrahpaşa, Istanbul University, Princess Margaret Cancer Centre

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154708581

Cites:

Cited by: 1

Related to: